BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 17117757)

  • 1. Histopathology of calcific aortic valve stenosis.
    Somers P; Knaapen M; Mistiaen W
    Acta Cardiol; 2006 Oct; 61(5):557-62. PubMed ID: 17117757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel mouse model of aortic valve stenosis induced by direct wire injury.
    Honda S; Miyamoto T; Watanabe T; Narumi T; Kadowaki S; Honda Y; Otaki Y; Hasegawa H; Netsu S; Funayama A; Ishino M; Nishiyama S; Takahashi H; Arimoto T; Shishido T; Miyashita T; Kubota I
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):270-8. PubMed ID: 24311378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathogenesis of calcific aortic valve stenosis].
    Kaden JJ
    Herz; 2006 Oct; 31(7):620-8. PubMed ID: 17072774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early calcific stenosis of aortic and mitral Ionescu-Shiley valves in a patient with bioprosthetic infection.
    Williams EH; Gonti VR; Nishimura A; Stout LC; Ferrans V
    J Thorac Cardiovasc Surg; 1981 Sep; 82(3):391-7. PubMed ID: 7278328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is it time for a new paradigm in calcific aortic valve disease?
    Owens DS; Otto CM
    JACC Cardiovasc Imaging; 2009 Aug; 2(8):928-30. PubMed ID: 19679279
    [No Abstract]   [Full Text] [Related]  

  • 6. Osseous and chondromatous metaplasia in calcific aortic valve stenosis.
    Torre M; Hwang DH; Padera RF; Mitchell RN; VanderLaan PA
    Cardiovasc Pathol; 2016; 25(1):18-24. PubMed ID: 26386747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The response to valve injury. A paradigm to understand the pathogenesis of heart valve disease.
    Li C; Xu S; Gotlieb AI
    Cardiovasc Pathol; 2011; 20(3):183-90. PubMed ID: 21075649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic and local levels of fetuin-A in calcific aortic valve stenosis.
    Kaden JJ; Reinöhl JO; Blesch B; Brueckmann M; Haghi D; Borggrefe M; Schmitz F; Klomfass S; Pillich M; Ortlepp JR
    Int J Mol Med; 2007 Aug; 20(2):193-7. PubMed ID: 17611637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical therapy for calcific aortic stenosis.
    Salas MJ; Santana O; Escolar E; Lamas GA
    J Cardiovasc Pharmacol Ther; 2012 Jun; 17(2):133-8. PubMed ID: 21828284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbonic anhydrase XII in valve interstitial cells promotes the regression of calcific aortic valve stenosis.
    Bouchareb R; Côté N; Marie-Chloé-Boulanger ; Le Quang K; El Husseini D; Asselin J; Hadji F; Lachance D; Shayhidin EE; Mahmut A; Pibarot P; Bossé Y; Messaddeq Y; Boudreau D; Marette A; Mathieu P
    J Mol Cell Cardiol; 2015 May; 82():104-15. PubMed ID: 25771146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The progression of calcific aortic valve disease through injury, cell dysfunction, and disruptive biologic and physical force feedback loops.
    Li C; Xu S; Gotlieb AI
    Cardiovasc Pathol; 2013; 22(1):1-8. PubMed ID: 22795219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factor Egr-1 in calcific aortic valve disease.
    Ghazvini-Boroujerdi M; Clark J; Narula N; Palmatory E; Connolly JM; DeFelice S; Xu J; Jian B; Hazelwood S; Levy RJ
    J Heart Valve Dis; 2004 Nov; 13(6):894-903. PubMed ID: 15597579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Could activated tissue remodeling be considered as early marker for progressive valve degeneration? Comparative analysis of checkpoint and ECM remodeling gene expression in native degenerating aortic valves and after bioprosthetic replacement.
    Yeghiazaryan K; Skowasch D; Bauriedel G; Schild H; Golubnitschaja O
    Amino Acids; 2007 Jan; 32(1):109-14. PubMed ID: 16874466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiologic mechanisms of calcific aortic stenosis.
    Alexopoulos A; Kaoukis A; Papadaki H; Pyrgakis V
    Ther Adv Cardiovasc Dis; 2012 Apr; 6(2):71-80. PubMed ID: 22361851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonrheumatic calcific aortic stenosis: an overview from basic science to pharmacological prevention.
    Parolari A; Loardi C; Mussoni L; Cavallotti L; Camera M; Biglioli P; Tremoli E; Alamanni F
    Eur J Cardiothorac Surg; 2009 Mar; 35(3):493-504. PubMed ID: 19162497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differences between degenerative (non-inflammatory) calcinosis- related stenosis of the aortic valve and the rheumatic calcinosis- induced aortic valve stenosis].
    Kushakovskiĭ MS; Baliabin AA
    Kardiologiia; 1991 Jan; 31(1):56-9. PubMed ID: 2046252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathology of calcific aortic stenosis.
    Ladich E; Nakano M; Carter-Monroe N; Virmani R
    Future Cardiol; 2011 Sep; 7(5):629-42. PubMed ID: 21929343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopontin alters endothelial and valvular interstitial cell behaviour in calcific aortic valve stenosis through HMGB1 regulation.
    Passmore M; Nataatmadja M; Fung YL; Pearse B; Gabriel S; Tesar P; Fraser JF
    Eur J Cardiothorac Surg; 2015 Sep; 48(3):e20-9. PubMed ID: 26273067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring calcific aortic valve disease: the role of biomarkers.
    Latsios G; Tousoulis D; Androulakis E; Papageorgiou N; Synetos A; Tsioufis C; Toutouzas K; Stefanadis C
    Curr Med Chem; 2012; 19(16):2548-54. PubMed ID: 22489716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone regulatory factors NFATc1 and Osterix in human calcific aortic valves.
    Alexopoulos A; Bravou V; Peroukides S; Kaklamanis L; Varakis J; Alexopoulos D; Papadaki H
    Int J Cardiol; 2010 Mar; 139(2):142-9. PubMed ID: 19019468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.